Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
-
NeuBase Therapeutics (NBSE) Announces Proposed Public Offering of Common Stock
-
NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
-
NeuBase Therapeutics to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th
-
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
NeuBase Therapeutics (NBSE) Prices 5.25M Share Common Offering at $6/Sh
-
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
-
Chardan Capital Markets Starts NeuBase Therapeutics (NBSE) at Buy
-
NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference

